Company news

Presentation at SIO 2024

Dr. Kyle Schachtschneider, Vice President of R&D and Services for Sus Clinicals, Inc. will present exciting research from the Oncopig Cancer ModelĀ® at the Society of Interventional Oncology Annual Meeting later this month.

Read article